Role of MicroRNA-124 as a Prognostic Factor in Multiple Neoplasms: A Meta-Analysis

Table 2

Essential features and overall survival of the studies contained in this meta-analysis.

Study	Year	High expression	Low expression	OS				DFS/PFS				Nationality	Malignant disease	Source of HR
				HR	LL	UL	value	HR	LL	UL	value
Zheng	2011	65	66	NM				0.400	0.200	0.800	0.009	China	HCC	Reported
Wang	2012	25	71	0.216	0.081	0.578	0.002	0.221	0.084	0.577	0.002	China	Colorectal	Reported
Takafumi	2014	25	24	0.147	0.008	0.789	0.022	0.624	0.291	1.300	0.209	Japan	Colorectal	SC
Chen	2014	69	68	0.550	0.300	0.990	0.001	0.560	0.320	0.970	0.002	China	Glioma	Reported
Henriett	2015	NM	NM	0.385	0.138	0.912	0.032	0.485	0.169	1.205	0.121	Canada	ccRCC	Reported
Dong	2015	67	66	0.316	0.110	0.559	0.017	NM				China	Breast cancer	SC
Han	2015	53	52	0.680	0.290	1.600	0.005	NM				China	Osteosarcoma	Reported
Li	2014	48	116	0.136	0.034	0.534	0.004	0.168	0.044	0.644	0.009	China	NSCLC	Reported
Wang	2014	32	33	0.652	0.461	0.922	0.015	NM				China	PDAC	SC
Zhang	2015	46	46	0.340	0.150	0.730	<0.05	0.300	0.120	0.730	<0.05	China	NSCLC	SC
Cui	2016	15	15	0.800	0.240	2.680	<0.05	NM				China	NSCLC	SC
Dong	2016	20	20	0.610	0.110	3.330	0.002	0.630	0.150	2.610	0.006	Japan	Cervical cancer	Reported
Feng	2016	24	24	0.506	0.201	1.274	0.015	NM				China	Breast cancer	Reported
Li	2016	57	70	0.362	0.135	0.974	0.044	NM				China	Cervical cancer	Reported
Sun	2016	18	35	0.405	0.247	0.800	0.001	NM				China	PDAC	SC
Xu	2016	20	20	0.890	0.200	3.920	0.017	NM				China	HCC	Reported
Wu	2017	NM	NM	0.452	0.373	0.568	0.002	NM				China	HCC	Reported
Jin	2017	96	99	0.330	0.190	0.500	<0.01	NM				China	NSCLC	Reported
Cong	2017	55	59	0.282	0.177	0.725	0.019	0.255	0.156	0.637	0.012	China	Osteosarcoma	SC
Li	2017	40	48	0.424	0.260	0.670	<0.05	NM				China	Gastric cancer	Reported
Luo	2017	NM	NM	0.680	0.520	0.730	0.023	NM				China	NSCLC	Reported
Yulia	2017	17	50	5.400	1.800	16.000	0.002	2.400	1.000	5.700	0.050	Israel	Ependymoma	Reported
Long	2018	NM	NM	0.659	0.523	0.830	0.036	0.460	0.230	0.950	0.026	China	HCC	SC
Liu	2018	51	70	0.550	0.270	1.110	0.002	0.620	0.330	1.180	0.009	China	Gastric cancer	Reported

NM: not mentioned; SC: survival curve; Colorectal: colorectal cancer.